RxDoctor Payments Data

Chad Blankenship, PA

Physician Assistant · Concord, NCNPI 1598062879

Payments from drug & device makers

$3,919in general payments, 2019–2025

Across 206 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Johnson & Johnson$620
  • Otsuka America Pharmaceutical, Inc.$540
  • Alkermes, Inc.$457
  • E.r. Squibb & Sons, L.L.C.$429
  • AbbVie$403
  • plus $440 from 6 others

What the payments were for

  • Food & beverage$3,67994%
  • Education$2406%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,919 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$14,282
Medicare patients
52
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate20$197,794
Invega SustennaPaliperidone Palmitate66$176,460
UzedyRisperidone19$79,431
Abilify MaintenaAripiprazole27$73,556
VraylarCariprazine Hcl24$35,070
AristadaAripiprazole Lauroxil11$30,387
RexultiBrexpiprazole13$20,029
Risperdal ConstaRisperidone Microspheres15$17,305
Aripiprazole140$7,798
Haloperidol Decanoate81$4,041
Divalproex Sodium ErDivalproex Sodium79$3,595
Fluphenazine Decanoate35$3,582
Paliperidone ErPaliperidone32$3,067
Olanzapine105$2,625
Haloperidol74$1,802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna, Risperdal Consta$620$391,559101 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$540$93,58440 claims
Teva Pharmaceuticals USA, Inc.Uzedy$1,029$79,43119 claims
AbbVieVraylar$403$35,07024 claims
Alkermes, Inc.Aristada$457$30,38711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Concord

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →